On Wednesday, Nova received a positive adjustment to its Relative Strength (RS) Rating, from 68 to 73.
This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the trailing 52 weeks matched up against all other stocks.
Decades of market research reveals that the top-performing stocks often have an 80 or better RS Rating in the early stages of their moves. See if Nova can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Nova has moved more than 5% past a 190.51 entry in a second-stage consolidation, meaning it's now out of a proper buy zone. Look for the stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings-per-share growth declined last quarter from 52% to 41%, but sales rose from 28% to 39%.
The company earns the No. 1 rank among its peers in the Electronics-Semiconductor Equipment industry group. Onto Innovation and KLA are also among the group's highest-rated stocks.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
